Serving Patients
Through Collaboration

Amgen’s expertise in these core areas enables us to collaborate with stakeholders across the healthcare industry—and beyond.

Population
Health

Read more

Population
Health

Amgen aims to improve patient health by identifying gaps in care management and supporting the Triple Aim Initiatives to improve care, reduce cost, and enhance the patient experience. This includes identifying shared population health priorities to facilitate cross-functional engagements and partnerships.

Read less

Healthcare Solutions
Development

Read more

Healthcare Solutions
Development

Amgen partners with innovators in the tight against serious illnesses and leverages innovation at every stage of discovery.

Read less

Patient
Centricity

Read more

Patient
Centricity

Amgen develops new approaches and techniques to engage with patients, incorporating the patient voice across the patient journey to help drive choice and adherence.

Read less

Digital
Health

Read more

Digital
Health

Amgen serves patients through the discovery, development, and application of emerging digital solutions. Our incubation and development platform gathers, evaluates, funds, and expands digital opportunities.

Read less

Global Health Economics
and Observational
Research

Read more

Global Health Economics
and Observational
Research

Amgen establishes partnerships with payers, providers, and other stakeholders who share our focus on improving patient health outcomes and demonstrating clinical and economic value. To achieve this, we produce evidence on disease burden and generate economic/health/ patient-reported outcomes. We also forecast and profile diseases; provide epidemiologic expertise to explore real-world outcomes; and contribute excellence in clinical program design and implementation.

Read less

Examples of
Amgen Working With...

References: 1. Business Wire. Harvard Pilgrim Negotiates First-In-The Nation Innovative Contract for Blockbuster Cholesterol Drug Repatha. www.businesswire.com/news/home/20151109006090/en/Harvard-Pilgrim-Negotiates-First-In-The-Nation-Innovative-Contract. Accessed January 7, 2020. 2. Amgen. Amgen And Harvard Pilgrim Agree To First Cardiovascular Outcomes-Based Refund Contract For Repatha® (Evolocumab). www.amgen.com/media/news-releases/2017/05/amgen-and-harvard-pilgrim-agree-to-first-cardiovascular-outcomesbased-refund-contract-for-repatha-evolocumab/. Accessed January 7, 2020. 3. Harvard Pilgrim. Harvard Pilgrim Signs Outcomes-Based Contract with Amgen for Enbrel. www.harvardpilgrim.org/public/news-detail?nt=HPH_News_C&nid=1471912468296. Accessed January 7, 2020. 4. Amgen. Amgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With Employers. www.amgen.com/media/news-releases/2018/06/amgen-and-health-and-benefits-consultant-piper-jordan-partner-on-first-migraine-project-with-employers/. Accessed January 7, 2020. 5. Amgen. Amgen And Humana Partner For Improved Health Outcomes And Efficiency. www.amgen.com/media/news-releases/2017/08/-amgen-and-humana-partner-for-improved-health-outcomes-and-efficiency/. Accessed January 7, 2020.